Pacira BioSciences, Inc. (PCRX) › Weighted Average Diluted SharesPacira BioSciences, Inc. (PCRX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2009-12-31: 573.1K2010-12-31: 574.1K2011-12-31: 16.44M2013-12-31: 33.18M2014-12-31: 35.30M2015-12-31: 41.30M2016-12-31: 37.24M2017-12-31: 39.81M2018-12-31: 40.91M2019-12-31: 41.51M2020-12-31: 43.68M2021-12-31: 45.63M2022-12-31: 46.54M2023-12-31: 51.98M2024-12-31: 46.24M2025-12-31: 45.04M45.04M2009-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3145.04M-2.6%2026-02-26From 2025-01-012024-12-3146.24M-11.0%2026-02-26From 2024-01-012023-12-3151.98M+11.7%2026-02-26From 2023-01-012022-12-3146.54M+2.0%2025-02-27From 2022-01-012021-12-3145.63M+4.5%2024-02-29From 2021-01-012020-12-3143.68M+5.2%2023-02-28From 2020-01-012019-12-3141.51M+1.5%2022-02-28From 2019-01-012018-12-3140.91M+2.8%2021-03-01From 2018-01-012017-12-3139.81M+6.9%2020-02-21From 2017-01-012016-12-3137.24M-9.8%2018-02-28From 2016-01-012015-12-3141.30M+17.0%2018-02-28From 2015-01-012014-12-3135.30M+6.4%2016-02-25From 2014-01-012013-12-3133.18M—2016-02-25From 2013-01-012011-12-3116.44M+2763.3%2012-03-27From 2011-01-012010-12-31574.1K+0.2%2012-03-27From 2010-01-012009-12-31573.1K—2012-03-27From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)